Sumitomo Pharma Co. Ltd.

In News

Sumitomo Pharma's (TSE:4506) Attractive Earnings Are Not All Good News For Shareholders - simplywall.st

simplywall.st - Aug 09, 2026

Sumitomo Pharma America Earns 2026-2027 Great Place to Work Certification™ - businesswire.com

businesswire.com - Aug 06, 2026

Sumitomo Pharma Co. Ltd. R (DPM.DU) Q4 FY2025 earnings call transcript - Yahoo Finance

Yahoo Finance - Aug 07, 2026

Short seller Gotham City Research accuses Sumitomo Pharma of misstating revenue - Investing.com

Investing.com - Aug 04, 2026

Sumitomo Pharma Rejects Allegations in Gotham City Research Report - The Globe and Mail

The Globe and Mail - Aug 05, 2026

Sumitomo Pharma Co., Ltd. 2027 Q1 - Results - Earnings Call Presentation (OTCMKTS:DNPUF) 2026-08-01 - Seeking Alpha

Seeking Alpha - Aug 01, 2026

Sumitomo Pharma (4506) Q1 2027 earnings summary - Quartr

Quartr - Jul 31, 2026

Sumitomo Pharma Denies Allegations of Misstatements, Inappropriate Accounting - marketscreener.com

marketscreener.com - Aug 04, 2026

Sumitomo Pharma: Revenue up 19.9% and net profit up 51.7% year-over-year, led by U.S. sales and FX gains - TradingView

TradingView - Jul 31, 2026

Sumitomo Pharma Co Ltd (DPM.DU) stock price, news, quote and history - Yahoo Finance UK

Yahoo Finance UK - Aug 03, 2026

Sumitomo Pharma America Announces Enzomenib (DSP-5336) Receives FDA Orphan Drug Designation for Treatment of Acute Lymphoblastic Leukemia - businesswire.com

businesswire.com - Jul 30, 2026

Sumitomo Pharma Flags Uncertainty in Q1 FY2026 Outlook - The Globe and Mail

The Globe and Mail - Aug 01, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment